Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)
Dana-Farber
February 26, 2025
Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.